# ETFs That Hold Genscript Biotech Corp (1548) > 38 thematic and core ETFs hold Genscript Biotech Corp (1548). GNOM holds the most, at 3.81% of the fund on Aug 31, 2026. Data as of Nov 5, 2026. Rebuilt every trading night. ## ETFs that hold Genscript Biotech Corp 38 thematic and core ETFs hold Genscript Biotech Corp , by holdings dated Jun 30, 2026 to Nov 3, 2026 . GNOM holds the most, at 3.81% of the fund on Aug 31, 2026 . The next largest are FPA (1.23%) and PIE (0.91%). ### Thematic and core funds that hold it | Fund | Name | Share of the fund | Holdings filed | Asset | | --- | --- | --- | --- | --- | | GNOM | Global X Genomics & Biotechnology ETF | 3.81% | Aug 31, 2026 | Equity | | FPA | First Trust Asia Pacific ex-Japan AlphaDEX Fund | 1.23% | Nov 3, 2026 | Equity | | PIE | Invesco Dorsey Wright Emerging Markets Momentum ETF | 0.91% | Nov 3, 2026 | Equity | | MCH | Matthews China Active ETF | 0.51% | Jun 30, 2026 | Equity | | FDT | First Trust Developed Markets ex-US AlphaDEX Fund | 0.32% | Nov 3, 2026 | Equity | | AVEE | Avantis Emerging Markets Small Cap Equity ETF | 0.26% | Nov 2, 2026 | Equity | | GXC | State Street SPDR S&P China ETF | 0.15% | Nov 3, 2026 | Equity | | CXSE | WisdomTree China ex-State-Owned Enterprises Fund | 0.14% | Jun 30, 2026 | Equity | | AVSE | Avantis Responsible Emerging Markets Equity ETF | 0.11% | Nov 2, 2026 | Equity | | AVEM | Avantis Emerging Markets Equity ETF | 0.10% | Nov 3, 2026 | Equity | | FLCH | Franklin FTSE China ETF | 0.08% | Jun 30, 2026 | Equity | | GEM | Goldman Sachs ActiveBeta Emerging Markets Equity ETF | 0.06% | Aug 31, 2026 | Equity | | AVES | Avantis Emerging Markets Value ETF | 0.06% | Nov 2, 2026 | Equity | | EMCR | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF | 0.06% | Aug 31, 2026 | Equity | | VWO | Vanguard FTSE Emerging Markets ETF | 0.06% | Sep 30, 2026 | Equity | | GSEE | Goldman Sachs MarketBeta Emerging Markets Equity ETF | 0.06% | Aug 31, 2026 | Equity | | GMF | State Street SPDR S&P Emerging Asia Pacific ETF | 0.05% | Nov 3, 2026 | Equity | | DFEM | Dimensional Emerging Markets Core Equity 2 ETF | 0.05% | Jul 31, 2026 | Equity | | SCHE | Schwab Emerging Markets Equity ETF | 0.05% | Aug 31, 2026 | Equity | | DBEM | Xtrackers MSCI Emerging Markets Hedged Equity ETF | 0.04% | Aug 31, 2026 | Equity | | EEMX | State Street SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF | 0.04% | Nov 3, 2026 | Equity | | BBEM | JPMorgan BetaBuilders Emerging Markets Equity ETF | 0.04% | Nov 3, 2026 | Equity | | SPEM | State Street SPDR Portfolio Emerging Markets ETF | 0.04% | Nov 3, 2026 | Equity | | DFEV | Dimensional Emerging Markets Value ETF | 0.04% | Jul 31, 2026 | Equity | | XSOE | WisdomTree Emerging Markets ex-State-Owned Enterprises Fund | 0.03% | Jun 30, 2026 | Equity | | DFAE | Dimensional Emerging Core Equity Market ETF | 0.03% | Jul 31, 2026 | Equity | | DBAW | Xtrackers MSCI All World ex US Hedged Equity ETF | 0.02% | Aug 31, 2026 | Equity | | DFAX | Dimensional World ex U.S. Core Equity 2 ETF | 0.02% | Jul 31, 2026 | Equity | | BKEM | BNY Mellon Emerging Markets Equity ETF | 0.02% | Jul 31, 2026 | Equity | | CWI | State Street SPDR MSCI ACWI ex-US ETF | 0.02% | Nov 3, 2026 | Equity | | VSGX | Vanguard ESG International Stock ETF | 0.02% | Sep 30, 2026 | Equity | | VEU | Vanguard FTSE All World Ex US ETF | 0.02% | Sep 30, 2026 | Equity | | FLAX | Franklin FTSE Asia ex Japan ETF | 0.01% | Jun 30, 2026 | Equity | | VXUS | Vanguard Total International Stock ETF | 0.01% | Sep 30, 2026 | Equity | | GXUS | Goldman Sachs MarketBeta Total International Equity ETF | 0.01% | Aug 31, 2026 | Equity | | TLTE | Northern Trust Morningstar Emerging Markets Factor Tilt ETF | 0.01% | Jul 31, 2026 | Equity | | SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.01% | Nov 3, 2026 | Equity | | VT | Vanguard Total World Stock Index ETF | 0.01% | Sep 30, 2026 | Equity | ### What this counts Genscript Biotech Corp (ticker 1548, listed in KY) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund’s N-PORT asset type. A fund holding only the company’s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out. Each row shows the date the fund last filed. Look up another company . ### Questions people ask Which ETFs hold Genscript Biotech Corp? 38 thematic and core ETFs hold Genscript Biotech Corp, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are GNOM at 3.81% of the fund on Aug 31, 2026, FPA at 1.23% of the fund on Nov 3, 2026 and PIE at 0.91% of the fund on Nov 3, 2026. --- Source: ETFIQ, independent ETF data. Recomputed nightly from public filings and prices. Cite: ETFIQ, ETFs holding GENSCRIPT BIOTECH CORP, data as of Nov 5, 2026. https://etfiq.com/holdings/genscript-biotech-corp/ Licence: https://etfiq.com/license/ Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms. HTML: https://etfiq.com/holdings/genscript-biotech-corp/